Kaumann A J
ICI Pharmaceuticals Division, Mereside, Macclesfield, Cheshire, U.K.
J Cardiovasc Pharmacol. 1988;11 Suppl 1:S88-92.
The mode of interaction of some alpha-adrenoceptor ligands with the 5-HT2-receptor system was investigated in the calf coronary artery. Isometric contractions caused by 5-hydroxytryptamine (5-HT) were studied on strips without endothelium. Phentolamine antagonized competitively (pKB = 7.4) the effects of 5-HT. Phentolamine also prevented the methysergide-induced depression of contractions elicited by 5-HT. The alpha 1-selective ligand 127I-HEAT depressed the responses to 5-HT. Both phentolamine and ketanserin prevented the depressant effects of I-HEAT on 5-HT-induced contractions. These and previous experiments are consistent with the existence of the 5-HT2 receptor in two interconvertible states R in equilibrium with R'. Interconversions between the high affinity state R and low affinity state R' (for 5-HT) appear to be modulated by an allosteric site A. The present and previous data suggest four possible modes of interaction of alpha-adrenoceptor ligands with the 5-HT2-receptor system: (a) ligands that compete with 5-HT for the 5-HT2 receptor in the R state (examples are nonselective phentolamine, alpha 1-selective ketanserin and corynanthine, and alpha 2-selective yohimbine and rauwolscine); (b) ligands such as I-HEAT that through binding to A depress the response to 5-HT by favouring the R' state; (c) ligands, such as ketanserin and phentolamine, that through binding to A favour the R state; and (d) ligands, such as phenoxybenzamine, that cause a covalent modification of the R state but not of the R' state. Qualitative and quantitative considerations suggest that in the calf coronary artery the described features are unrelated to alpha 1- and alpha 2-adrenoceptors.
在小牛冠状动脉中研究了一些α-肾上腺素能受体配体与5-羟色胺2(5-HT2)受体系统的相互作用模式。在无内皮的血管条上研究了5-羟色胺(5-HT)引起的等长收缩。酚妥拉明竞争性拮抗(pKB = 7.4)5-HT的作用。酚妥拉明还可防止麦角新碱引起的由5-HT诱发的收缩抑制。α1选择性配体127I-HEAT可抑制对5-HT的反应。酚妥拉明和酮色林均可防止127I-HEAT对5-HT诱发收缩的抑制作用。这些实验以及先前的实验结果均与5-HT2受体以两种可相互转化的状态R和R'处于平衡状态的存在相一致。高亲和力状态R和低亲和力状态R'(对5-HT而言)之间的相互转化似乎受变构位点A的调节。目前和先前的数据表明α-肾上腺素能受体配体与5-HT2受体系统存在四种可能的相互作用模式:(a)在R状态下与5-HT竞争5-HT2受体的配体(例如非选择性的酚妥拉明、α1选择性的酮色林和育亨宾、α2选择性的育亨宾和萝芙木碱);(b)诸如127I-HEAT之类的配体,通过与A结合,促进R'状态,从而抑制对5-HT的反应;(c)诸如酮色林和酚妥拉明之类的配体,通过与A结合,促进R状态;(d)诸如酚苄明之类的配体,可导致R状态而非R'状态的共价修饰。定性和定量分析表明,在小牛冠状动脉中,所描述的这些特征与α1和α2肾上腺素能受体无关。